In-house IP roundup: USPTO eligibility guidance could create consistency; advice and anecdotes on protecting IP in China

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

In-house IP roundup: USPTO eligibility guidance could create consistency; advice and anecdotes on protecting IP in China

thumb

Patent Strategy, a new service from Managing IP, rounds up the latest news and analysis from patent-focused businesses

1. Tech and life sciences: USPTO eligibility guidance could create consistency

Barclays, Regeneron, Amadeus and others say the new guidance on Section 101-related subject matter could lead to more reliable patent examinations – and may mark the start of a post-Alice framework reversal.

(Read more … ) 



2. Advice and anecdotes on protecting IP in China

At Managing IP’s International Patent Forum in London in March, panellists gave colourful examples of how foreign companies can go about protecting their IP in China.

(Read more … )



3. How businesses choose between trade secrets and patents

In-house counsel say that deciding between a trade secret and a patent requires looking at patentability, potential infringement detection, and whether an invention could realistically be kept under wraps.

(Read more … )







Sign up to receive more content like this in Patent Strategy’s weekly newsletter.


more from across site and SHARED ros bottom lb

More from across our site

The Texas-based IP litigation hires take King & Spalding’s partner appointments from pre-merger Winston & Strawn up to 12 this year
Sunny Su explains how her team overcame challenges with orchard evidence collection to secure a favourable plant variety decision from China’s top court
Flexible working firm continues trajectory from 2025 with appointment of Matthew Grant and Letao Qin
Anousha Davies, associate and trademark attorney at Birketts, unpicks how the university’s reputation enabled it to see off a proposed trademark for ‘Cambridge Rowing’
IP lawyers, who say they are encouraging clients to build up ‘tariff resilience’, should treat the risks posed by recent orders as a core consideration in cross-border licensing
Regulatory changes and damages risks are prompting Canadian firms and clients to opt for settlements in generic and biosimilar cases
News of Via Licensing Alliance adding two new members and Nokia’s proposal to extend interim licences to Warner Bros Discovery and Paramount were also among the top talking points
A new claim filed by Ericsson, and a request for access to documents, were also among recent developments
Cooley and Stikeman Elliott advised 35Pharma on the deal, which will allow GSK to get its hands on S235, an investigational medicine for pulmonary hypertension
Simon Wright explains why the UK should embrace the possibility of rejoining the UPC, and reveals how CIPA is reacting to this month’s historic Emotional Perception AI case at the UK Supreme Court
Gift this article